Obeticholic acid, a Farensoid-X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
Hepatology
.
2014 Nov;60(5):1798-9.
doi: 10.1002/hep.27123.
Epub 2014 May 9.
Authors
Rajeshwar Mookerjee
1
,
Gautam Mehta
,
Rajiv Jalan
Affiliation
1
Liver Failure Group, UCL Institute for Liver and Digestive Health, The Royal Free Hospital, London, United Kingdom.
PMID:
24623154
DOI:
10.1002/hep.27123
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Chenodeoxycholic Acid / analogs & derivatives*
Hypertension, Portal / drug therapy*
Male
Signal Transduction / physiology*
Substances
Chenodeoxycholic Acid